CIDARA THERAPEUTICS, INC. Operating Lease, Expense
CIDARA THERAPEUTICS, INC. reported Operating Lease, Expense of $400.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2025-11-06
- CIDARA THERAPEUTICS, INC. operating lease, expense for the quarter ending 2025-09-30 was $400.00K, a 20.00% decline year-over-year.
- CIDARA THERAPEUTICS, INC. operating lease, expense for the quarter ending 2025-06-30 was $400.00K, a 20.00% decline year-over-year.
- CIDARA THERAPEUTICS, INC. operating lease, expense for the quarter ending 2025-03-31 was $400.00K, a 0.00% change year-over-year.
- CIDARA THERAPEUTICS, INC. operating lease, expense for the quarter ending 2024-12-31 was $400.00K, a 0.00% change year-over-year.
- CIDARA THERAPEUTICS, INC. operating lease, expense for fiscal 2024 was $1.70M, a 6.25% increase from fiscal 2023.
- CIDARA THERAPEUTICS, INC. operating lease, expense for fiscal 2023 was $1.60M, a 23.08% increase from fiscal 2022.
- CIDARA THERAPEUTICS, INC. operating lease, expense for fiscal 2022 was $1.30M, a 8.33% increase from fiscal 2021.
- CIDARA THERAPEUTICS, INC. operating lease, expense for fiscal 2021 was $1.20M, a 20.00% increase from fiscal 2020.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-06 | $800.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.30M 10-Q · filed 2025-11-06 | $1.60M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | $400.00K 10-Q · filed 2025-08-07 | $800.00K 10-Q · filed 2025-08-07 | $1.20M derived: sum of 3 quarters · filed 2025-08-07 | $1.70M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | $400.00K 10-Q · filed 2025-05-08 | $800.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.30M derived: sum of 3 quarters · filed 2025-11-06 | $1.80M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $900.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.40M derived: sum of 3 quarters · filed 2025-11-06 | $1.70M 10-K · filed 2025-03-06 |
| 2024-09-30 | $500.00K 10-Q · filed 2025-11-06 | $1.00M derived: sum of 2 quarters · filed 2025-11-06 | $1.30M 10-Q · filed 2025-11-06 | $1.80M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $500.00K 10-Q · filed 2025-08-07 | $900.00K 10-Q · filed 2025-08-07 | $1.30M derived: sum of 3 quarters · filed 2025-08-07 | $1.70M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $400.00K 10-Q · filed 2025-05-08 | $800.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.20M derived: sum of 3 quarters · filed 2025-05-08 | $1.70M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $800.00K derived: sum of 2 quarters · filed 2025-03-06 | $1.30M derived: sum of 3 quarters · filed 2025-03-06 | $1.60M 10-K · filed 2025-03-06 |
| 2023-09-30 | $400.00K 10-Q · filed 2024-11-07 | $900.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.20M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $800.00K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $300.00K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $1.30M 10-K · filed 2024-04-22 | |||
| 2021-12-31 | $1.20M 10-K · filed 2023-03-23 | |||
| 2020-12-31 | $1.00M 10-K · filed 2023-03-23 | |||
| 2019-12-31 | $1.00M 10-K · filed 2022-03-07 |